American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
David G. Pfister(Memorial Sloan Kettering Cancer Center), Mark R. Somerfield(American Society of Clinical Oncology), Christopher G. Azzoli(Massachusetts General Hospital), Thomas J. Smith(Sidney Kimmel Cancer Center), Andrew T. Turrisi(American Society of Clinical Oncology), John R. Strawn(American Society of Clinical Oncology), Jemi Olak(American Society of Clinical Oncology), David H. Johnson(Boston Children's Hospital), Sherman Baker(American Society of Clinical Oncology), Diane E. Stover(American Society of Clinical Oncology), William T. Sause(LDS Hospital)
Cited by 1,426
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1
|Journal of Clinical Oncology|2004|1.7k
American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer
|Journal of Clinical Oncology|2004|1.5k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k